Cellectis (CLLS) Net Cash Flow (2015 - 2026)

Cellectis' Net Cash Flow history runs 12 years deep, the most recent figure standing at -$26.5 million for Q1 2026.

• In Q1 2026, Net Cash Flow fell 55.49% year-over-year to -$26.5 million; the TTM figure through Mar 2026 stood at -$95.1 million (down 1757.56% YoY), while the FY2025 annual figure was -$85.6 million, down 1021.52% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$26.5 million, down from $8.0 million in the prior quarter.
• The five-year high for Net Cash Flow was $67.6 million in Q4 2023, with the low at -$67.3 million in Q2 2025.
• The 5-year median for Net Cash Flow is -$13.8 million (2024), against an average of -$9.3 million.
• The sharpest annual moves came in 2024 and 2025: Net Cash Flow jumped 2538.29% in 2024, then sank 377.39% in 2025.
• Cellectis' Net Cash Flow stood at -$15.6 million in 2022, then surged by 532.45% to $67.6 million in 2023, then sank by 120.38% to -$13.8 million in 2024, then soared by 157.69% to $8.0 million in 2025, then tumbled by 432.98% to -$26.5 million in 2026.
• Business Quant data shows CLLS's Net Cash Flow at -$26.5 million in Q1 2026, $8.0 million in Q4 2025, and -$9.3 million in Q3 2025.